Podolsky D K, Isselbacher K J
Biochem J. 1982 Nov 15;208(2):249-59. doi: 10.1042/bj2080249.
Cancer-associated galactosyltransferase acceptor (CAGA glycoprotein), a small glycoprotein purified from human malignant effusion that selectively kills transformed cells, was tritiated by reductive methylation in the presence of NaB(3)H(4). CAGA-glycoprotein-sensitive cells (baby-hamster kidney cells transformed by polyoma virus and chick-embryo fibroblasts infected with Ts68 temperature-sensitive mutant of Rous sarcoma virus grown at 37 degrees C, the permissive temperature) bound 3-5-fold more (3)H-labelled CAGA glycoprotein than did their CAGA-glycoprotein-resistant non-transformed counterparts. The Rous-sarcoma-virus-infected chick-embryo fibroblasts grown at non-permissive temperature (41 degrees C) bound an intermediate amount of (3)H-labelled CAGA glycoprotein; however, this intermediate amount appeared to be sufficient to induce inhibition of cell growth when the infected chick-embryo fibroblasts treated at 41 degrees C were switched to 37 degrees C. Binding of (3)H-labelled CAGA glycoprotein was time- and temperature-dependent and was not inhibited by monosaccharide. Binding was completely inhibited by the oligosaccharide liberated by endoglucosaminidase H treatment or by exhaustive Pronase digestion of intact CAGA glycoprotein. However, the isolated oligosaccharide failed to demonstrate the growth-inhibition characteristics of the intact glycopeptide. Binding of (3)H-labelled CAGA glycoprotein was unaffected by co-incubation with the peptide core released by endoglucosaminidase H treatment. (3)H-labelled CAGA glycoprotein bound to intact cells could be removed by trypsin treatment up to 4h after addition of the glycoprotein but not thereafter. This time course paralleled the decreasing reversibility of growth inhibition. However, all (3)H-labelled CAGA glycoprotein was found in the supernatant when cells were first disrupted by sonication followed by trypsin treatment for up to 12h. (3)H-labelled CAGA glycoprotein linked to Sepharose 4B failed to cause growth inhibition in CAGA-glycoprotein-sensitive cells. These findings suggest that binding of CAGA glycoprotein occurs via its oligosaccharide moiety. Binding appears to be a necessary but not sufficient condition to induce cell killing. Growth inhibition appears to depend on internalization of the glycoprotein and the presence of a transformation-specific cell process.
癌症相关半乳糖基转移酶受体(CAGA糖蛋白)是一种从人恶性积液中纯化得到的小糖蛋白,能选择性杀死转化细胞,在NaB(3)H(4)存在的情况下通过还原甲基化进行了氚标记。CAGA糖蛋白敏感细胞(由多瘤病毒转化的幼仓鼠肾细胞以及在允许温度37℃下生长的感染了劳斯肉瘤病毒Ts68温度敏感突变体的鸡胚成纤维细胞)比其对CAGA糖蛋白有抗性的未转化对应细胞结合的3H标记CAGA糖蛋白多3至5倍。在非允许温度(41℃)下生长的感染劳斯肉瘤病毒的鸡胚成纤维细胞结合中等量的3H标记CAGA糖蛋白;然而,当在41℃处理的感染鸡胚成纤维细胞切换到37℃时,这个中等量似乎足以诱导细胞生长抑制。3H标记CAGA糖蛋白的结合具有时间和温度依赖性,且不受单糖抑制。结合完全被内切葡糖胺酶H处理释放的寡糖或完整CAGA糖蛋白经胰蛋白酶彻底消化所抑制。然而,分离出的寡糖未能表现出完整糖肽的生长抑制特性。与内切葡糖胺酶H处理释放的肽核心共同孵育不影响3H标记CAGA糖蛋白的结合。添加糖蛋白后长达4小时,胰蛋白酶处理可去除结合到完整细胞上的3H标记CAGA糖蛋白,但此后则不能。这个时间进程与生长抑制的可逆性降低平行。然而,当细胞首先通过超声破碎然后进行长达12小时的胰蛋白酶处理时,所有3H标记CAGA糖蛋白都出现在上清液中。与琼脂糖4B偶联的3H标记CAGA糖蛋白未能在CAGA糖蛋白敏感细胞中引起生长抑制。这些发现表明CAGA糖蛋白的结合通过其寡糖部分发生。结合似乎是诱导细胞杀伤的必要但不充分条件。生长抑制似乎取决于糖蛋白的内化以及转化特异性细胞过程的存在。